Dr. Fraser Brown is a partner in the patent counseling and prosecution practice. His practice focuses on biotechnology issues, with particular emphasis on drafting and prosecuting patent applications, and preparing invalidity, freedom to operate and patentability opinions. Fraser has also negotiated agreements to further clients' collaborative research and development strategies. He has counseled clients on a range of technical areas including vaccines, fluorescent proteins, drug design and screening, and cancer therapies.

Download full bio 


  • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 

  • SuppreMol GmbH: Acquired by Baxter International 

  • Vascular Biogenics Prices IPO 

  • T2 Biosystems IPO 

  • Adamas Pharmaceuticals Initial Public Offering 

  • View all


  • Georgetown University Law Center
    JD, 2008

  • University of Birmingham
    PhD, 1998

  • University of Glasgow
    BS, 1994

Admissions & Credentials


District of Columbia

Limited Recognition to practice before the United States Patent & Trademark Office (USPTO)

Rankings & Accolades

    Legal 500: Top Lawyer for Patent Prosecution